Paola Lattus

Leaders celebrate topping out of UT Health San Antonio Multispecialty and Research Hospital

Retrieved on: 
Monday, October 17, 2022
SAN, Wurzbach Parkway, Dignitary Protection, Transplant, Culture, Paola Lattus, Media, FACP, Patient, National Cancer Institute, MBA, University of Texas System, Integral, Research, Workforce, MRI, UT System, Bone marrow, Technology, Relaxation, University, Connecticut Board of Regents for Higher Education, CT, Capital, University of Texas Health Science Center at San Antonio, Board, List, Adult, MACP, Environment, Infection, UT Health San Antonio Cancer Center, South Texas Medical Center, University of Texas at Austin, Interior design, Hospital, Medicine, Health insurance, MD

SAN ANTONIO, Texas, Oct.17, 2022 /PRNewswire-PRWeb/ -- Surgeries in multiple specialties, new services for the region including stem cell therapies and bone marrow transplants, and access to the latest clinical research trials are drawing closer to reality as construction of the half-a-billion-dollar UT Health San Antonio Multispecialty and Research Hospital reaches an important milestone in the South Texas Medical Center.

Key Points: 
  • The half-a-billion-dollar UT Health San Antonio Multispecialty and Research Hospital, a world-class facility with technology and ambience backing up superb medical teams, has reached the topping out mark in its construction.
  • Leaders of The University of Texas Health Science Center at San Antonio (UT Health San Antonio), community supporters and general contractor Vaughn Construction celebrated the hospital's topping out and beam-signing ceremony today.
  • "Admitting hospital patients who are part of clinical research efforts is not done in our community now," said William L. Henrich, MD, MACP , president of The University of Texas Health Science Center at San Antonio (UT Health San Antonio).
  • The University of Texas Health Science Center at San Antonio (UT Health San Antonio), a primary driver for San Antonio's $42.4 billion health care and biosciences sector, is the largest research university in South Texas with an annual research portfolio of $350 million.

NuVasive to Sponsor and Participate at EUROSPINE 2022

Retrieved on: 
Monday, October 17, 2022
SAN, News, Royal Orthopaedic Hospital, NuVasive, Deformity, Hospital, Efficiency, Paola Lattus, Workflow, Society, Birmingham Children's Hospital, NASDAQ, Patient, Siemens Healthineers, SPS, Trust law, Surgeon, Expert, Multimedia, Lausanne University Hospital, Partnership, Technology, Spine, Software, Company, Great Ormond Street Hospital, X360, Elective surgery, Medical imaging, Medical device, Pulse

SAN DIEGO, Oct. 17, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will continue its partnership with EUROSPINE as a gold sponsor and will attend EUROSPINE 2022 held October 19 to 21 in Milan.

Key Points: 
  • SAN DIEGO, Oct. 17, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will continue its partnership with EUROSPINE as a gold sponsor and will attend EUROSPINE 2022 held October 19 to 21 in Milan.
  • "Through our industry-leading set of procedural solutions, enabled by the technologies within Pulse, we continue to build the future of spine care to deliver more intelligent surgery."
  • NuVasivewill host a lunch workshop,Pulse: Where accuracy meets innovation,onWednesday, October 19from11:45 to 13:45 CESTinRoom Brown 2of Milano Convention Centre.Mr.
  • NuVasive, Inc.(NASDAQ: NUVA) is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives.

Radiofrequency Based Devices Global Market Report 2022: RF Waves' Applications in Numerous Medical Specialties Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 13, 2022
Mobile, Wireless, Technology, Hardware, European Medical Devices Industry Group, Time, Prevalence, Paola Lattus, Cardiology, Radio frequency, Patient, Hospital, Income, Electrode, Research, Pain management, Cancer, RF, US, Incidence, Conditional sentence, Patent, Brain, Chronic pain, Heat, COVID-19, Worldwide, Medical imaging, Growth

The "Radiofrequency Based Devices Market, Global Forecast 2022-2027, Industry Trends, Growth, Size, Impact of COVID-19, Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Radiofrequency Based Devices Market, Global Forecast 2022-2027, Industry Trends, Growth, Size, Impact of COVID-19, Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • Moreover, the competition in the global radiofrequency-based aesthetic devices market will intensify in the future, owing to new market entrants and patent expiration.
  • The growing geriatric population and increasing focus on enhancing physical appearance are significant factors driving radiofrequency-based devices market growth.
  • Based on application, the radiofrequency-based devices market has been segmented into aesthetics devices, pain management devices, oncology devices, gynaecology devices, cardiology devices, and others.

Banner Health, Atlas Healthcare Partners open surgery centers dedicated to pain and cardiovascular services

Retrieved on: 
Wednesday, October 12, 2022
Physician, OBL, McCormick Ranch, ASC, Paola Lattus, Patient, Banner Health, Research, Pain management, Electrophysiology, Partnership, Spine, Acquisition, 3D ultrasound, Pain, Rehabilitation, Banner, MD Anderson Cancer Center, Philips, Microsoft Partner Network, Health insurance, Hospital

PHOENIX, Oct.12, 2022 /PRNewswire/ -- Atlas Healthcare Partners, in partnership with Banner Health, today announces the acquisition of two new ambulatory surgical centers (ASCs) in Scottsdale and Tucson, Arizona, bringing its total to 27 ASCs.

Key Points: 
  • The rapid addition of Banner Surgery Centers has markedly increased access to high-quality healthcare in the region with critical expansion of service line offerings in an outpatient setting.
  • These additional ASCs represent how the Banner/Atlas Healthcare Partners Network is growing:
    Banner Surgery Center Desert Vista, located near McCormick Ranch in Scottsdale, Arizona, will feature two operating rooms.
  • Banner Cardiovascular Center Tanque Verde was converted from an office-based laboratory (OBL) to an ASC to better serve surgery patients.
  • Atlas Healthcare Partners (Atlas) specializes in the development and management of ambulatory surgery centers (ASCs) in partnership with health systems and physicians.

Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Consulting Services Agreement with Information Technology Company, Softhread

Retrieved on: 
Wednesday, October 12, 2022
Medical Supplies, Biotechnology, Technology, Health, Pharmaceutical, Infectious Diseases, Artificial Intelligence, Networks, Internet, Mobile, Wireless, COVID-19, Pillar, Health, Health policy, U.S. Securities and Exchange Commission, Nurses station, Drug Quality and Security Act, Technology, Population, Paola Lattus, Pharmacy, Science, Acceleration, Laboratory, Policy, Strategic planning, PHI, NASDAQ, Patient, Privacy, American University of Integrative Sciences, Agreement, MBA, Security (finance), Confidentiality, Securities Act of 1933, Clinical, Artificial intelligence, Data management, ROI, Solution, Company, MD, Industry, AI, Information technology, Board, Blockchain, Internet, Consultant, Securities Exchange Act of 1934, Business Consulting International, CCI, Cryptocurrency, Medical device, Hospital, Healthcare, Pharmaceutical industry

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the Company or Novo), and Clinical Consultants International (CCI), a Novo wholly-owned subsidiary, today announced the signing of a Consulting Services Agreement (the Agreement), which includes revenue-sharing potential, with Softhread, Inc., an information technology company which offers a proprietary, patent-pending blockchain and AI-enabled platform that preserves confidentiality and optimizes network security, while enhancing operational efficiency.

Key Points: 
  • Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the Company or Novo), and Clinical Consultants International (CCI), a Novo wholly-owned subsidiary, today announced the signing of a Consulting Services Agreement (the Agreement), which includes revenue-sharing potential, with Softhread, Inc., an information technology company which offers a proprietary, patent-pending blockchain and AI-enabled platform that preserves confidentiality and optimizes network security, while enhancing operational efficiency.
  • Together, we are also exploring the integration of Softhreads technology into Novo Connect, Novos proprietary mobile application, to further enhance a secure and reliable consumer experience.
  • Softhread brings a modular blockchain architecture for the veracity and security of information exchanges among all IoT-connected Health Care 4.0 stakeholders.
  • Innovation through science combined with the integration of sophisticated, secure technology assures Novo Integrated Sciences of continued cutting-edge advancement in patient first platforms.

Avail Medsystems to Participate at Upcoming Industry and Investor Conferences

Retrieved on: 
Wednesday, October 12, 2022
Adoption, Paola Lattus, Machine learning, Organization, Medtech, Technology, Surgery, Software, Industry, AI, Health, Emerging technologies, Silicon, Next wave, Medical device

Forum: "Technologies Ushering in Next-Generation Diagnostics, Therapies, and Surgeries" Panel

Key Points: 
  • Forum: "Technologies Ushering in Next-Generation Diagnostics, Therapies, and Surgeries" Panel
    Avail enables the MedTech industry and healthcare providers to work together more often and more efficiently, harnessing expertise and technology in and out of the OR to accelerate the innovation, adoption, and reach of tools and techniques to improve patient care.
  • Avail does this by placing a consistent, mobile, hardware platform with integrated software into operating rooms, audibly and visually connecting remote participants and serving as the hub for advanced digital capabilities including AI and machine learning, in a secure cloud-based digital telepresence network.
  • Today, 50 MedTech organizations have contracted with Avail to rethink commercial models, reduce inefficiencies, and enhance the reach and timeliness of collaboration.
  • Avail was founded in 2017 by MedTech veterans with a vision to leverage Silicon Valley technology expertise to evolve the industry and enable MedTech and healthcare to deliver the best care possible.

KRONOS ADVANCED TECHNOLOGIES ANNOUNCES THE FORMATION OF A NEW MEDICAL DEVICE MANUFACTURING SUBSIDIARY, KRONOSMD INC, TO FOCUS THIS DIVISION ON MEDICAL DEVICES AND PRECISION MEDICAL COMPONENTS MANUFACTURING

Retrieved on: 
Wednesday, October 12, 2022
News, Healthcare Facilities Accreditation Program, Electronics, Prevalence, Efficiency, Growth, Review, Paola Lattus, Virus, OTC Markets Group, B2B, Purification, CAGR, Original equipment manufacturer, Bloomberg Businessweek, Indoor air quality, Research, Social media, KRONOS, DOGE, Allergen, Technology, CORE, Solution, Company, Marketing, Acquisition, Health, Car, Disinfectant, Conditional sentence, University, Bacteria, OTC, HEPA, GLOBE, Medical device, Forward-looking statement, KNOS, Atmosphere, Public policy, IAQ, USD, School, Pharmaceutical industry, Public relations, Kronos

This investment, focusing on leading-edge technology in the medical electronic device industry, demonstrates Kronos commitment to the future of our company.

Key Points: 
  • This investment, focusing on leading-edge technology in the medical electronic device industry, demonstrates Kronos commitment to the future of our company.
  • This announcement formalizes the creation of KronosMD, a new division with a dedicated team to pursue medical device acquisitions and B2B manufacturing business opportunities.
  • The medical device and new medical technologies market are growing exponentially.
  • As part of our future initiatives, Kronos quality management and manufacturing systems have been developed to meet the required industry standards for the manufacturing of medical devices.

Baptist Health and LeanTaaS’ Collaboration in Improving Operating Room Utilization Included in 2022 Gartner® Case Study

Retrieved on: 
Thursday, October 6, 2022
Data Management, Health, Technology, Hospitals, Surgery, Software, Artificial Intelligence, Barrow Neurological Institute, LinkedIn, Health care, Hospital, Paola Lattus, Stroke, Machine learning, Baptists, Patient, Psychology, Research, Twitter, Publication, Utilization, Oklahoma Baptist Homes for Children, MD Anderson Cancer Center, National Accreditation Board for Hospitals & Healthcare Providers, Facebook, Technology, Solution, OR, Coast, Leadership, Health, Baptist Health, Surgeon, Gartner

The recently published Case Study: Take an AI-Based Approach to Operating Room Scheduling and Utilization (Gartner, Barry Runyon, August 2022) states that effective OR scheduling optimization can improve case throughput, OR capacity and utilization, clinician satisfaction and retention, patient experience measures, and healthcare provider revenue.

Key Points: 
  • The recently published Case Study: Take an AI-Based Approach to Operating Room Scheduling and Utilization (Gartner, Barry Runyon, August 2022) states that effective OR scheduling optimization can improve case throughput, OR capacity and utilization, clinician satisfaction and retention, patient experience measures, and healthcare provider revenue.
  • As a large, complex, and busy integrated delivery network with 5 hospitals, 74 operating rooms, and approximately 47,000 surgeries annually, Baptist Health wanted to increase the utilization of its OR suites.
  • Engaging LeanTaaS was an important step in improving OR utilization throughout Baptist Health hospitals, said Amy Cate Huveldt, Vice President of Performance Excellence, Baptist Health, Jacksonville.
  • We have a truly collaborative relationship with Baptist Health, and were thrilled to see iQueue for Operating Rooms featured as a use case in a Gartner Case Study, said Ashley Walsh, Vice President, Client Services, iQueue for Operating Rooms.

Hyperfine Names Maria Sainz President and Chief Executive Officer

Retrieved on: 
Thursday, October 6, 2022
Adoption, High-dependency unit, U.S. Securities and Exchange Commission, ICU, Therapy, Technology, Audit committee, Growth, Paola Lattus, Humanitarian use licenses, Magnetic resonance imaging, Butterfly network, Intelligence, Patient, Hospital, Income, Security (finance), MRI, Partnership, Private Securities Litigation Reform Act, Marketing, Industry, AI, Board, The Cooper Companies, CEO, Health, National Medal, GLOBE, Jonathan Rothberg, DNA, National Medal of Technology and Innovation, Clarify Op3nvoice, FDA, COVID-19, List of life sciences, Stryker, Management, Risk management, Swoop, Nasdaq, Hyperfine structure

GUILFORD, Conn., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), (Hyperfine or the Company), the groundbreaking medical device company that created Swoop, the world's first FDA-cleared portable MRI system, today announced that it has named medical device industry veteran Maria Sainz as President and Chief Executive Officer (CEO) of Hyperfine, effective October 24, 2022.

Key Points: 
  • GUILFORD, Conn., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), (Hyperfine or the Company), the groundbreaking medical device company that created Swoop, the world's first FDA-cleared portable MRI system, today announced that it has named medical device industry veteran Maria Sainz as President and Chief Executive Officer (CEO) of Hyperfine, effective October 24, 2022.
  • Scott Huennekens, who currently serves as interim President and CEO, will stay on as Executive Chairperson of the Board.
  • As President and CEO of Hyperfine, Ms. Sainz will lead the commercial expansion of Hyperfines Swoop portable MRI system to execute the companys mission of lowering barriers to medical imaging around the world.
  • We are very pleased to name Ms. Sainz President and CEO of Hyperfine.

Blue-Zone Technologies, Ltd. Secures $8 Million of Institutional Financing

Retrieved on: 
Tuesday, October 4, 2022
Mont Blanc, Anesthetic, Health Canada, GMP, Knowledge, Clermont-Ferrand, Sale, Lyon, Venture capital, Angers, CEO, Health, ACM, Hospital, Time, Physician, Loire-Atlantique, Targobank, LLC, Company, High-dependency unit, GLOBE, CIC, Caen, Technology, Paola Lattus, Industry, Regulation and licensure in engineering, Inhalation, Environment, Investment, Project assurance, National Society of Certified Healthcare Business Consultants, Pharmaceutical industry, Financial services, Blue Zone

In addition to the financial investment, we will leverage their extensive network and in-depth knowledge of the global healthcare sector.

Key Points: 
  • In addition to the financial investment, we will leverage their extensive network and in-depth knowledge of the global healthcare sector.
  • The next 12 months will be an exciting time for Blue-Zone as we scale-up our operation and accelerate our commercial efforts.
  • The companys mission is to reduce hospitals hazardous environmental waste and lower financial costs by applying Blue-Zones patented technology.
  • Round Pond Ventures, LLC is an investment arm of HPC Holdings, Inc (the holding company for the Halocarbon Family of Companies).